Search Login Register

cabergoline Summary

344 relevant articles (75 outcomes, 67 trials/studies) found for this Drug

Description: also acts as prolactin antagonist

Also Known As: 1-((6-allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea; 1-ethyl-2-(3'-dimethylaminopropyl)-3-(6'-allylergoline-8'-beta-carbonyl)urea diphosphate; Cabaser; Cabaseril; Dostinex Show All >>

Key Diseases for which cabergoline is Relevant

  1. Parkinson Disease (Parkinson's Disease) : 16 outcomes 28 studies in 88 results
  2. Prolactinoma (Prolactinomas) : 15 outcomes 8 studies in 80 results
  3. Neoplasms (Cancer) : 9 outcomes 6 studies in 45 results
  4. Hyperprolactinemia : 9 outcomes 3 studies in 49 results
  5. Dyskinesias (Dyskinesia) : 7 outcomes 3 studies in 24 results
Show All >>

Drugs Related to cabergoline

  1. Dopamine Agonists (Dopamine Agonist)
  2. Levodopa (L Dopa)
  3. Prolactin
  4. Bromocriptine (Parlodel)
  5. Pergolide (Permax)
  6. Risperidone (Risperdal Consta)
  7. Octreotide (Sandostatin)
  8. pramipexol (pramipexole)
  9. ropinirole (Requip)
  10. Carbon Monoxide
Show All >>

Therapies Related to cabergoline

  1. Activities of Daily Living (ADL)
  2. Drug Therapy (Chemotherapy)
  3. Aftercare (After-Treatment)
  4. Transplantation (Transplant Recipients)
  5. Decompression
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2008 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.